SlideShare a Scribd company logo
USE OF
CORTICOSTEROIDS AND NSAIDS IN RA
MONA YADAV
GROUP 3
CORTICOSTEROIDS
• Corticosteroids are also called steroids.
These drugs can help reduce inflammation
in RA. They may also help reduce the pain
and damage caused by inflammation.
CORTICOSTEROIDS
• glucocorticoids :-
• A) hormones :- hydrocortisone ( cortisol)
• B) synthetic :-
• Prednisolone
• Prednisone
• Methylprednisolone
• Dexamethasone
• Betamethasone
• Triamcinolone
CORTICOSTEROIDS
• 1 ) Prednisone :- is an immunosuppressant for the treatment of
autoimmune disorders; it may decrease inflammation by reversing
increased capillary permeability and suppressing
polymorphonuclear leukocyte activity. Prednisone stabilizes
lysosomal membranes and suppresses lymphocytes and antibody
production.
• dose :- Immediate-release: ≤10 mg/day PO added (DMARDs)
• Delayed-release: 5 mg/day PO initially, maintenance: lowest
dosage that maintains clinical response; may be taken at bedtime
to decrease morning stiffness with rheumatoid arthritis
CORTICOSTEROIDS
• 2) Methylprednisolone :- decreases inflammation by suppressing
the migration of polymorphonuclear leukocytes (PMNs) and
reversing increased capillary permeability.
• dose :- 40 mg/day PO divided q6-24hr.
• 3) SIDE EFFECT OF CORTICOSTEROIDS:-
• Hyperglycemia - due to increased gluconeogenesis
• Steroid-induced osteoporosis: reduced bone density
• Adrenal insufficiency (if used for long time and stopped suddenly)
NON- STEROIDAL ANTI- INFLAMMATORY DRUGS
NSAIDs are the most commonly used RA drugs.
• NSAIDs interfere with prostaglandin synthesis through
inhibition of the enzyme cyclooxygenase (COX), thus
reducing swelling and pain.
• TYPES :-
• a) acetic acid derivatives
• b) Carboxylic acid derivatives
• c) Proprionic acid derivatives
NSAIDS
• drugs :- Ibuprofen
• Naproxen
• Diclofenac
• Ketoprofen
• Celecoxib
• Aspirin
• 1 ) Ibuprofen is indicated for patients with mild to moderate
pain. It inhibits inflammatory reactions and pain by decreasing
prostaglandin synthesis.
• dose - 400mg po q6-8hr , not exceed 3000 mg/day
NSAIDS
• 2) Naproxen :- This agent inhibits inflammatory reactions and
pain by decreasing the activity of cyclooxygenase, which is
responsible for prostaglandin synthesis.
• dose - 500-1000 mg/day PO divided q12hr; may increase to
1500 mg/day if tolerated well for limited time.
• 3) Diclofenac :- is one of a series of phenylacetic acids that
have demonstrated anti-inflammatory and analgesic
properties. It is inhibit COX, which is essential in the
biosynthesis of prostaglandins.
• Diclofenac can cause hepatotoxicity; therefore, liver enzymes
NSAIDS
• dose :- Diclofenac sodium: 50 mg PO q8hr or 75 mg PO
q12hr.
• 4) Celecoxib is approved for the relief of signs and symptoms
of RA. It primarily inhibits COX-2, which is considered an
inducible isoenzyme (induced during pain and inflammatory
stimuli). Inhibition of COX-1 may contribute to NSAID
gastrointestinal (GI) toxicity. Administer the lowest possible
dose for each patient. Use of celecoxib has been associated
with an increased risk of cardiovascular toxicity.
• dose - 100-200 mg PO q12hr
NSAIDS
• side effect of nsaids: -
• Stomach problems like bleeding, ulcer and stomach upset
• High blood pressure
• Fluid retention (causing swelling, such as around the
lower legs, feet, ankles and hands)
• Rashes.
 NSAID's presentation

More Related Content

What's hot

NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
Suvarta Maru
 
NSAIDs- (for Allied health sciences)
NSAIDs- (for Allied health sciences)NSAIDs- (for Allied health sciences)
NSAIDs- (for Allied health sciences)Subramani Parasuraman
 
Detoxification of ibuprofen
Detoxification of ibuprofenDetoxification of ibuprofen
Detoxification of ibuprofen
Herman Franklin Ndjamen
 
Alina Wilkinson Chem 499 Poster fall 2015(final revision)
Alina Wilkinson Chem 499 Poster fall 2015(final revision)Alina Wilkinson Chem 499 Poster fall 2015(final revision)
Alina Wilkinson Chem 499 Poster fall 2015(final revision)Alina Wilkinson
 
Remicade presentation
Remicade presentationRemicade presentation
Remicade presentation
Sanjida Sultana
 
Non Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugsNon Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugs
lalchand67
 
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRYNsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
MAYURI SOMPURA
 
Nsaids slideshare
Nsaids slideshareNsaids slideshare
Nsaids slideshare
mayurisompura
 
anti inflammatory drugs
anti inflammatory drugsanti inflammatory drugs
anti inflammatory drugs
dosemanju
 
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiCyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Nur Hajriya
 
NSAIDs
NSAIDsNSAIDs
Anti_inflammatory_drugs
Anti_inflammatory_drugsAnti_inflammatory_drugs
Anti_inflammatory_drugs
Suman Bhattarai
 
Anti Inflammatory drugs - Modern and Ayurveda
Anti Inflammatory drugs - Modern and AyurvedaAnti Inflammatory drugs - Modern and Ayurveda
Anti Inflammatory drugs - Modern and Ayurveda
Abhilash Mu
 
Aceclofenac
AceclofenacAceclofenac
Nsaids new/cosmetic dentistry courses
Nsaids new/cosmetic dentistry coursesNsaids new/cosmetic dentistry courses
Nsaids new/cosmetic dentistry courses
Indian dental academy
 
Assignment On cox2 inhibitors
Assignment On cox2 inhibitorsAssignment On cox2 inhibitors
Assignment On cox2 inhibitorsMugdha Padhye
 
1. final 14 2 nsai-ds
1. final 14 2 nsai-ds1. final 14 2 nsai-ds
1. final 14 2 nsai-ds
Lama K Banna
 
NSAIDs in Periodontology
NSAIDs in PeriodontologyNSAIDs in Periodontology
NSAIDs in Periodontology
Shilpa Shiv
 

What's hot (20)

NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
NSAIDs- (for Allied health sciences)
NSAIDs- (for Allied health sciences)NSAIDs- (for Allied health sciences)
NSAIDs- (for Allied health sciences)
 
Cox 1,2 inhibitors
Cox 1,2 inhibitorsCox 1,2 inhibitors
Cox 1,2 inhibitors
 
Detoxification of ibuprofen
Detoxification of ibuprofenDetoxification of ibuprofen
Detoxification of ibuprofen
 
Alina Wilkinson Chem 499 Poster fall 2015(final revision)
Alina Wilkinson Chem 499 Poster fall 2015(final revision)Alina Wilkinson Chem 499 Poster fall 2015(final revision)
Alina Wilkinson Chem 499 Poster fall 2015(final revision)
 
Remicade presentation
Remicade presentationRemicade presentation
Remicade presentation
 
Non Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugsNon Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugs
 
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRYNsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
Nsaids slideshare NON STEROIDAL ANTI INFLAMMATORY DRUGS - CHEMISTRY
 
Nsaids slideshare
Nsaids slideshareNsaids slideshare
Nsaids slideshare
 
anti inflammatory drugs
anti inflammatory drugsanti inflammatory drugs
anti inflammatory drugs
 
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiCyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
 
NSAIDs
NSAIDsNSAIDs
NSAIDs
 
Anti_inflammatory_drugs
Anti_inflammatory_drugsAnti_inflammatory_drugs
Anti_inflammatory_drugs
 
Anti Inflammatory drugs - Modern and Ayurveda
Anti Inflammatory drugs - Modern and AyurvedaAnti Inflammatory drugs - Modern and Ayurveda
Anti Inflammatory drugs - Modern and Ayurveda
 
Aceclofenac
AceclofenacAceclofenac
Aceclofenac
 
Nsaids new/cosmetic dentistry courses
Nsaids new/cosmetic dentistry coursesNsaids new/cosmetic dentistry courses
Nsaids new/cosmetic dentistry courses
 
Assignment On cox2 inhibitors
Assignment On cox2 inhibitorsAssignment On cox2 inhibitors
Assignment On cox2 inhibitors
 
Nsaid
NsaidNsaid
Nsaid
 
1. final 14 2 nsai-ds
1. final 14 2 nsai-ds1. final 14 2 nsai-ds
1. final 14 2 nsai-ds
 
NSAIDs in Periodontology
NSAIDs in PeriodontologyNSAIDs in Periodontology
NSAIDs in Periodontology
 

Similar to NSAID's presentation

Analgesics-DH-Mani.pptx
Analgesics-DH-Mani.pptxAnalgesics-DH-Mani.pptx
Analgesics-DH-Mani.pptx
IQ CITY MEDICAL COLLEGE
 
Drugs affecting pain
Drugs affecting painDrugs affecting pain
Drugs affecting pain
Khaled Shurrab
 
Steroids in dentistry
Steroids in dentistrySteroids in dentistry
Steroids in dentistry
Shibani Sarangi
 
analgesics and corticosteroids
analgesics and corticosteroids analgesics and corticosteroids
analgesics and corticosteroids
Sanskriti Shah
 
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptxANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
NIKITA BHUTE
 
Endo-_Corticosteroids_in_Therapy.pdf
Endo-_Corticosteroids_in_Therapy.pdfEndo-_Corticosteroids_in_Therapy.pdf
Endo-_Corticosteroids_in_Therapy.pdf
SanjayaManiDixit
 
Non steroidal anti inflamatory drugs final presetation.pptx
Non steroidal anti inflamatory drugs final presetation.pptxNon steroidal anti inflamatory drugs final presetation.pptx
Non steroidal anti inflamatory drugs final presetation.pptx
shivanshverma55
 
Muscle releaxent toxicity
Muscle releaxent toxicityMuscle releaxent toxicity
Muscle releaxent toxicity
Ministry of health
 
Myasthenia gravis CTVA presentation
Myasthenia gravis CTVA presentationMyasthenia gravis CTVA presentation
Myasthenia gravis CTVA presentation
Kundan Ghimire
 
Myasthenia Gravis pharmacology pptx.pptx
Myasthenia Gravis pharmacology pptx.pptxMyasthenia Gravis pharmacology pptx.pptx
Myasthenia Gravis pharmacology pptx.pptx
SyedFurqan30
 
Dr tarek NSAIDs
Dr tarek NSAIDsDr tarek NSAIDs
Dr tarek NSAIDs
al azhar universty
 
Steroids in dentistry
Steroids in dentistrySteroids in dentistry
Steroids in dentistry
Amritha James
 
NonOpioid-Analgesics, Painkillers, NSAIDS
NonOpioid-Analgesics, Painkillers, NSAIDSNonOpioid-Analgesics, Painkillers, NSAIDS
NonOpioid-Analgesics, Painkillers, NSAIDS
dodo321
 
ANTI ALLERGIC DRUGS.pptx
ANTI ALLERGIC DRUGS.pptxANTI ALLERGIC DRUGS.pptx
ANTI ALLERGIC DRUGS.pptx
AgnimaAnne
 
NSAIDS Non Steroidal Anti-inflammatory Drugs
NSAIDS Non Steroidal Anti-inflammatory DrugsNSAIDS Non Steroidal Anti-inflammatory Drugs
NSAIDS Non Steroidal Anti-inflammatory Drugs
BikashAdhikari26
 
NSAID , GOUT.pdf
NSAID , GOUT.pdfNSAID , GOUT.pdf
NSAID , GOUT.pdf
Eiman Akram
 
Analegesia.pptx
Analegesia.pptxAnalegesia.pptx
Analegesia.pptx
Ibrahim Elkathiri
 
Steroid therapy in children
Steroid therapy in childrenSteroid therapy in children
Steroid therapy in children
Devendra Nargawe
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
Chintan Doshi
 
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptxLecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
AmrDuski1
 

Similar to NSAID's presentation (20)

Analgesics-DH-Mani.pptx
Analgesics-DH-Mani.pptxAnalgesics-DH-Mani.pptx
Analgesics-DH-Mani.pptx
 
Drugs affecting pain
Drugs affecting painDrugs affecting pain
Drugs affecting pain
 
Steroids in dentistry
Steroids in dentistrySteroids in dentistry
Steroids in dentistry
 
analgesics and corticosteroids
analgesics and corticosteroids analgesics and corticosteroids
analgesics and corticosteroids
 
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptxANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
ANALGESIC AND ANTI-INFLAMMATORY AGENTS.pptx
 
Endo-_Corticosteroids_in_Therapy.pdf
Endo-_Corticosteroids_in_Therapy.pdfEndo-_Corticosteroids_in_Therapy.pdf
Endo-_Corticosteroids_in_Therapy.pdf
 
Non steroidal anti inflamatory drugs final presetation.pptx
Non steroidal anti inflamatory drugs final presetation.pptxNon steroidal anti inflamatory drugs final presetation.pptx
Non steroidal anti inflamatory drugs final presetation.pptx
 
Muscle releaxent toxicity
Muscle releaxent toxicityMuscle releaxent toxicity
Muscle releaxent toxicity
 
Myasthenia gravis CTVA presentation
Myasthenia gravis CTVA presentationMyasthenia gravis CTVA presentation
Myasthenia gravis CTVA presentation
 
Myasthenia Gravis pharmacology pptx.pptx
Myasthenia Gravis pharmacology pptx.pptxMyasthenia Gravis pharmacology pptx.pptx
Myasthenia Gravis pharmacology pptx.pptx
 
Dr tarek NSAIDs
Dr tarek NSAIDsDr tarek NSAIDs
Dr tarek NSAIDs
 
Steroids in dentistry
Steroids in dentistrySteroids in dentistry
Steroids in dentistry
 
NonOpioid-Analgesics, Painkillers, NSAIDS
NonOpioid-Analgesics, Painkillers, NSAIDSNonOpioid-Analgesics, Painkillers, NSAIDS
NonOpioid-Analgesics, Painkillers, NSAIDS
 
ANTI ALLERGIC DRUGS.pptx
ANTI ALLERGIC DRUGS.pptxANTI ALLERGIC DRUGS.pptx
ANTI ALLERGIC DRUGS.pptx
 
NSAIDS Non Steroidal Anti-inflammatory Drugs
NSAIDS Non Steroidal Anti-inflammatory DrugsNSAIDS Non Steroidal Anti-inflammatory Drugs
NSAIDS Non Steroidal Anti-inflammatory Drugs
 
NSAID , GOUT.pdf
NSAID , GOUT.pdfNSAID , GOUT.pdf
NSAID , GOUT.pdf
 
Analegesia.pptx
Analegesia.pptxAnalegesia.pptx
Analegesia.pptx
 
Steroid therapy in children
Steroid therapy in childrenSteroid therapy in children
Steroid therapy in children
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptxLecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
Lecture 13- Non Steroidal Anti- Inflammatory Drugs.pptx
 

More from MOHAMMAD NOUR AL SAEED

Differentiating between anxiety, syncope anaphylaxis and prompt management o...
Differentiating between anxiety,  syncope anaphylaxis and prompt management o...Differentiating between anxiety,  syncope anaphylaxis and prompt management o...
Differentiating between anxiety, syncope anaphylaxis and prompt management o...
MOHAMMAD NOUR AL SAEED
 
Role of procalcitonin in sepsis management
Role of procalcitonin in sepsis managementRole of procalcitonin in sepsis management
Role of procalcitonin in sepsis management
MOHAMMAD NOUR AL SAEED
 
Pelvic inflammatory disease
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
MOHAMMAD NOUR AL SAEED
 
Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB ) Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB )
MOHAMMAD NOUR AL SAEED
 
Strabismus
StrabismusStrabismus
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
MOHAMMAD NOUR AL SAEED
 
Controlling External Bleeding
Controlling External BleedingControlling External Bleeding
Controlling External Bleeding
MOHAMMAD NOUR AL SAEED
 
Liver transplantation
Liver transplantationLiver transplantation
Liver transplantation
MOHAMMAD NOUR AL SAEED
 
liver transplantation
liver transplantation liver transplantation
liver transplantation
MOHAMMAD NOUR AL SAEED
 
Ankylosing spondylitis. (ben)
Ankylosing spondylitis. (ben)Ankylosing spondylitis. (ben)
Ankylosing spondylitis. (ben)
MOHAMMAD NOUR AL SAEED
 
psoriatic arthritis
 psoriatic  arthritis psoriatic  arthritis
psoriatic arthritis
MOHAMMAD NOUR AL SAEED
 
Vasculities
VasculitiesVasculities
systemic scleroderma
systemic sclerodermasystemic scleroderma
systemic scleroderma
MOHAMMAD NOUR AL SAEED
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
MOHAMMAD NOUR AL SAEED
 
Gout by mohammad nour alsaeed
Gout by mohammad nour alsaeedGout by mohammad nour alsaeed
Gout by mohammad nour alsaeed
MOHAMMAD NOUR AL SAEED
 
Fibromyalgia
FibromyalgiaFibromyalgia
Dmards by fasel rafiq
Dmards by fasel rafiqDmards by fasel rafiq
Dmards by fasel rafiq
MOHAMMAD NOUR AL SAEED
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
MOHAMMAD NOUR AL SAEED
 

More from MOHAMMAD NOUR AL SAEED (20)

Differentiating between anxiety, syncope anaphylaxis and prompt management o...
Differentiating between anxiety,  syncope anaphylaxis and prompt management o...Differentiating between anxiety,  syncope anaphylaxis and prompt management o...
Differentiating between anxiety, syncope anaphylaxis and prompt management o...
 
Role of procalcitonin in sepsis management
Role of procalcitonin in sepsis managementRole of procalcitonin in sepsis management
Role of procalcitonin in sepsis management
 
Pelvic inflammatory disease
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
 
Analgesic
AnalgesicAnalgesic
Analgesic
 
Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB ) Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB )
 
Strabismus
StrabismusStrabismus
Strabismus
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
 
Controlling External Bleeding
Controlling External BleedingControlling External Bleeding
Controlling External Bleeding
 
Liver transplantation
Liver transplantationLiver transplantation
Liver transplantation
 
liver transplantation
liver transplantation liver transplantation
liver transplantation
 
Ankylosing spondylitis. (ben)
Ankylosing spondylitis. (ben)Ankylosing spondylitis. (ben)
Ankylosing spondylitis. (ben)
 
psoriatic arthritis
 psoriatic  arthritis psoriatic  arthritis
psoriatic arthritis
 
Vasculities
VasculitiesVasculities
Vasculities
 
systemic scleroderma
systemic sclerodermasystemic scleroderma
systemic scleroderma
 
SLE
SLESLE
SLE
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Gout by mohammad nour alsaeed
Gout by mohammad nour alsaeedGout by mohammad nour alsaeed
Gout by mohammad nour alsaeed
 
Fibromyalgia
FibromyalgiaFibromyalgia
Fibromyalgia
 
Dmards by fasel rafiq
Dmards by fasel rafiqDmards by fasel rafiq
Dmards by fasel rafiq
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 

Recently uploaded

TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 

Recently uploaded (20)

TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 

NSAID's presentation

  • 1. USE OF CORTICOSTEROIDS AND NSAIDS IN RA MONA YADAV GROUP 3
  • 2. CORTICOSTEROIDS • Corticosteroids are also called steroids. These drugs can help reduce inflammation in RA. They may also help reduce the pain and damage caused by inflammation.
  • 3. CORTICOSTEROIDS • glucocorticoids :- • A) hormones :- hydrocortisone ( cortisol) • B) synthetic :- • Prednisolone • Prednisone • Methylprednisolone • Dexamethasone • Betamethasone • Triamcinolone
  • 4. CORTICOSTEROIDS • 1 ) Prednisone :- is an immunosuppressant for the treatment of autoimmune disorders; it may decrease inflammation by reversing increased capillary permeability and suppressing polymorphonuclear leukocyte activity. Prednisone stabilizes lysosomal membranes and suppresses lymphocytes and antibody production. • dose :- Immediate-release: ≤10 mg/day PO added (DMARDs) • Delayed-release: 5 mg/day PO initially, maintenance: lowest dosage that maintains clinical response; may be taken at bedtime to decrease morning stiffness with rheumatoid arthritis
  • 5. CORTICOSTEROIDS • 2) Methylprednisolone :- decreases inflammation by suppressing the migration of polymorphonuclear leukocytes (PMNs) and reversing increased capillary permeability. • dose :- 40 mg/day PO divided q6-24hr. • 3) SIDE EFFECT OF CORTICOSTEROIDS:- • Hyperglycemia - due to increased gluconeogenesis • Steroid-induced osteoporosis: reduced bone density • Adrenal insufficiency (if used for long time and stopped suddenly)
  • 6. NON- STEROIDAL ANTI- INFLAMMATORY DRUGS NSAIDs are the most commonly used RA drugs. • NSAIDs interfere with prostaglandin synthesis through inhibition of the enzyme cyclooxygenase (COX), thus reducing swelling and pain. • TYPES :- • a) acetic acid derivatives • b) Carboxylic acid derivatives • c) Proprionic acid derivatives
  • 7. NSAIDS • drugs :- Ibuprofen • Naproxen • Diclofenac • Ketoprofen • Celecoxib • Aspirin • 1 ) Ibuprofen is indicated for patients with mild to moderate pain. It inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. • dose - 400mg po q6-8hr , not exceed 3000 mg/day
  • 8. NSAIDS • 2) Naproxen :- This agent inhibits inflammatory reactions and pain by decreasing the activity of cyclooxygenase, which is responsible for prostaglandin synthesis. • dose - 500-1000 mg/day PO divided q12hr; may increase to 1500 mg/day if tolerated well for limited time. • 3) Diclofenac :- is one of a series of phenylacetic acids that have demonstrated anti-inflammatory and analgesic properties. It is inhibit COX, which is essential in the biosynthesis of prostaglandins. • Diclofenac can cause hepatotoxicity; therefore, liver enzymes
  • 9. NSAIDS • dose :- Diclofenac sodium: 50 mg PO q8hr or 75 mg PO q12hr. • 4) Celecoxib is approved for the relief of signs and symptoms of RA. It primarily inhibits COX-2, which is considered an inducible isoenzyme (induced during pain and inflammatory stimuli). Inhibition of COX-1 may contribute to NSAID gastrointestinal (GI) toxicity. Administer the lowest possible dose for each patient. Use of celecoxib has been associated with an increased risk of cardiovascular toxicity. • dose - 100-200 mg PO q12hr
  • 10. NSAIDS • side effect of nsaids: - • Stomach problems like bleeding, ulcer and stomach upset • High blood pressure • Fluid retention (causing swelling, such as around the lower legs, feet, ankles and hands) • Rashes.